Bacterial fimbriae and their peptides activate human gingival epithelial cells through toll-like receptor 2

被引:145
作者
Asai, Y
Ohyama, Y
Gen, K
Ogawa, T
机构
[1] Asahi Univ, Sch Dent, Dept Oral Microbiol, Gifu 5010296, Japan
[2] Asahi Univ, Sch Dent, Dept Periodontol, Gifu 5010296, Japan
关键词
D O I
10.1128/IAI.69.12.7387-7395.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gingival epithelial cells are a central component of the barrier between oral microflora and internal tissues. Host responses to periodontopathic bacteria and surface components containing fimbriae are thought to be important in the development and progression of periodontal diseases. To elucidate this mechanism, we established immortalized human gingival epithelial cells (HGEC) that were transfected with human papillomavirus. HGEC predominantly expressed Toil-like receptor (TLR) 2, but not TLR4 or CD14. They also induced interleukin-8 (IL-8) production when stimulated with Porphyromonas gingivalis fimbriae and Staphylococcus aureus peptidoglycan, but not Escherichia coli-type synthetic lipid A. Furthermore, an active synthetic peptide composed of residues 69 to 73 (ALTTE) of the fimbrial subunit protein, derived from P. gingivalis and similar to a common component of cell wall peptidoglycans in parasitic bacteria, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), significantly induced IL-8 production and NF-kappaB activation in HGEC, and these cytokine-producing activities were augmented by a complex of soluble CD14 and lipopolysaccharide-binding protein (LBP). IL-8 production in HGEC stimulated with these bacterial components was clearly inhibited by mouse monoclonal antibody to human TLR2. These findings suggest that P. gingivalis fimbrial protein and its active peptide are capable of activating HGEC through TLR2.
引用
收藏
页码:7387 / 7395
页数:9
相关论文
共 54 条
  • [41] Takada H., 1985, IMMUNOL BACT CELL EN, P119
  • [42] TLR6: A novel member of an expanding Toll-like receptor family
    Takeuchi, O
    Kawai, T
    Sanjo, H
    Copeland, NG
    Gilbert, DJ
    Jenkins, NA
    Takeda, K
    Akira, S
    [J]. GENE, 1999, 231 (1-2) : 59 - 65
  • [43] Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway
    Takeuchi, O
    Kaufmann, A
    Grote, K
    Kawai, T
    Hoshino, K
    Morr, M
    Muhlradt, PF
    Akira, S
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (02) : 554 - 557
  • [44] Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
    Takeuchi, O
    Hoshino, K
    Kawai, T
    Sanjo, H
    Takada, H
    Ogawa, T
    Takeda, K
    Akira, S
    [J]. IMMUNITY, 1999, 11 (04) : 443 - 451
  • [45] LOCALIZED EXPRESSION OF MESSENGER-RNA FOR PHAGOCYTE-SPECIFIC CHEMOTACTIC CYTOKINES IN HUMAN PERIODONTAL INFECTIONS
    TONETTI, MS
    IMBODEN, MA
    GERBER, L
    LANG, NP
    LAISSUE, J
    MUELLER, C
    [J]. INFECTION AND IMMUNITY, 1994, 62 (09) : 4005 - 4014
  • [46] The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
    Underhill, DM
    Ozinsky, A
    Hajjar, AM
    Stevens, A
    Wilson, CB
    Bassetti, M
    Aderem, A
    [J]. NATURE, 1999, 401 (6755) : 811 - 815
  • [47] Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes
    Vesy, CJ
    Kitchens, RL
    Wolfbauer, G
    Albers, JJ
    Munford, RS
    [J]. INFECTION AND IMMUNITY, 2000, 68 (05) : 2410 - 2417
  • [48] Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8
    Wang, QL
    Dziarski, R
    Kirschning, CJ
    Muzio, M
    Gupta, D
    [J]. INFECTION AND IMMUNITY, 2001, 69 (04) : 2270 - 2276
  • [49] ASSOCIATION OF ORAL BACTEROIDES WITH GINGIVITIS AND ADULT PERIODONTITIS
    WHITE, D
    MAYRAND, D
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 1981, 16 (03) : 259 - 265
  • [50] WILLIS SA, 1995, J IMMUNOL, V154, P1399